Published on 9 May 2024 on Zacks via Yahoo Finance
IGM Biosciences, Inc. (IGMS) Reports Q1 Loss, Misses Revenue Estimates
IGM Biosciences, Inc. (IGMS) came out with a quarterly loss of $0.83 per share versus the Zacks Consensus Estimate of a loss of $0.84. This compares to loss of $1.33 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 1.19%. A quarter ago, it was expected that this company would post a loss of $1.06 per share when it actually produced a loss of $1.01, delivering a surprise of 4.72%.